Orange Book product · Brand (NDA)
KEFLIN
CEPHALOTHIN SODIUM
At a glance
Approved Prior to Jan 1, 1982
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
CEPHALOTHIN SODIUM
Strength
EQ 20GM BASE/VIAL
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
NDA 050482
Product number
007
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- 1987CEPHALOTHIN SODIUMGeneric (ANDA)
ANDA 062666 · ABRAXIS PHARM
- 1987CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINERGeneric (ANDA)
ANDA 062730 · BAXTER HLTHCARE
- 1985CEPHALOTHIN SODIUMGeneric (ANDA)
ANDA 062547 · ABBOTT
- 1985CEPHALOTHIN SODIUMGeneric (ANDA)
ANDA 062548 · ABBOTT
- 1985KEFLIN IN PLASTIC CONTAINERGeneric (ANDA)
ANDA 062549 · LILLY
- 1985CEPHALOTHINGeneric (ANDA)
ANDA 062426 · INTL MEDICATION
- 1984CEPHALOTHIN SODIUMGeneric (ANDA)
ANDA 062464 · BRISTOL
- 1984CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINERGeneric (ANDA)
ANDA 062422 · BAXTER HLTHCARE
- 1983SEFFINGeneric (ANDA)
ANDA 062435 · GLAXOSMITHKLINE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
